Litcius/Paper detail

BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis

Ziwei Hu, Shaozhe Cai, Yikai Yu, Yu Chen, Bei Wang, Di Wang, Rui Zeng, Xiaofeng He, Guifen Shen, Fei Yu, Zhipeng Zeng, Yuxue Chen, Xiaofang Luo, Ziyun Zhang, Peiling Zhang, Hui Xiong, Lin Bai, Ping Ye, Sheng‐Yan Lin, Jishuai Zhang, Cong Ye, Chunrui Li, Lingli Dong

2025Annals of the Rheumatic Diseases24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLupus nephritisRefractory (planetary science)CAR T-cell therapySystemic lupus erythematosusImmunologyComplete remissionDiseaseInternal medicineT cellChimeric antigen receptorChemotherapyImmune systemAstrobiologyPhysicsCAR-T cell therapy researchSystemic Lupus Erythematosus ResearchT-cell and B-cell Immunology
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis | Litcius